Product How it works Pricing Blog FAQ About Contact
Español English
EspañolEnglish
Log inCreate free account
Rezolute

Rezolute (NASDAQ: RZLT) insider transactions

In the twelve months to 10 November 2026, executives and directors of Rezolute reported 0 open-market sales and 9 open-market purchases of 132,750 shares ($235,879), by 5 people, according to the Form 4 filings they submitted to the SEC.

Latest transactions

The 20 most recent transactions in Rezolute shares reported on Form 4
DateInsiderRoleTransactionSharesPriceHeld afterFiling
21 October 2026Evans DaronCFOGift−16,000—395,400Form 4
21 October 2026Evans DaronCFOGift+4,000—11,000Form 4
21 October 2026Evans DaronCFOGift+4,000—11,000Form 4
2 September 2026Karnawat Sunil RatilalChief Commercial OfficerShares withheld for tax−2,267$4.5069,275Form 4
2 July 2026Evans DaronCFOShares withheld for tax−3,062$4.99411,400Form 4
2 July 2026Elam Nevan CCEOShares withheld for tax−8,004$4.99605,497Form 4
2 July 2026Roberts Brian KennethChief Medical OfficerShares withheld for tax−3,062$4.99293,851Form 4
30 March 2026Evans DaronCFOOpen-market purchase+10,000$2.85414,462Form 4
2 March 2026Elam Nevan CCEOShares withheld for tax−27,618$2.99613,501Form 4
2 March 2026Evans DaronCFOShares withheld for tax−11,438$2.99404,462Form 4
2 March 2026Roberts Brian KennethChief Medical OfficerShares withheld for tax−11,439$2.99296,913Form 4
16 December 2025Roberts Brian KennethChief Medical OfficerOpen-market purchase+28,000$1.70308,352Form 4
16 December 2025Hogenhuis WladimirDirectorOpen-market purchase+5,650$1.69119,675Form 4
15 December 2025Karnawat Sunil RatilalChief Commercial OfficerOpen-market purchase+12,000$1.6271,442Form 4
15 December 2025Karnawat Sunil RatilalChief Commercial OfficerOpen-market purchase+100$1.6071,542Form 4
15 December 2025Elam Nevan CCEOOpen-market purchase+32,000$1.59641,119Form 4
15 December 2025Evans DaronCFOOpen-market purchase+40,000$1.77415,900Form 4
15 December 2025Evans DaronCFOOpen-market purchase+2,500$1.797,000Form 4
15 December 2025Evans DaronCFOOpen-market purchase+2,500$1.797,000Form 4
19 November 2025Labrucherie Gil MDirectorGrant or award+21,000—55,500Form 4

Names appear as in the filing, surname first. A dash in the price column means the filing reports none, as in grants and gifts.

How to read the table

Only open-market purchases and sales are trades the insider chose to make at the market price, and they are the ones counted in the summary above. Grants, option exercises and shares withheld for tax come from pay plans. A sale marked as a 10b5-1 plan was scheduled in advance under a written plan.

Where each row comes from

From the Form 4 that each executive, director or large shareholder must file with the SEC within two business days of a transaction, read up to 10 November 2026. Each row links to its filing on EDGAR. Only transactions in shares are listed, not derivatives, and amended filings are left out. The accounts of the company are on the Rezolute page; the method, in data sources.

Information prepared from the Form 4 filings submitted to the SEC, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.